Ad is loading...
MENU

CLBT Stock Tickeron detected bearish Stock Pattern: Broadening Wedge Ascending CLBT on November 12, 2024, netting in a 6.71% gain over 7 days

A.I.dvisor
at Tickeron.com
Loading...
+6.71% Gain from a Successful pattern Broadening Wedge Ascending
CLBT - Cellebrite DI Ltd
Tickeron
Ticker: CLBT
Company: Cellebrite DI
Gain from shortening: +6.71%
Confirmed: 11/12/24
Succeeded: 11/13/24
Total length: 7 days
On November 06, 2024, A.I.dvisor detected a Broadening Wedge Ascending Pattern (Bearish) for Cellebrite DI Ltd (CLBT, $19.09). 6 days later, on November 12, 2024, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On November 13, 2024, the stock hit the target price of $17.74 – resulting in a gain for traders who shorted the stock on the pattern detection date.

CLBT in downward trend: price dove below 50-day moving average on November 15, 2024

CLBT moved below its 50-day moving average on November 15, 2024 date and that indicates a change from an upward trend to a downward trend. In of 34 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CLBT moved out of overbought territory on November 07, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 13, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CLBT as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CLBT turned negative on November 11, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLBT advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

CLBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 193 cases where CLBT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CLBT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (66.225) is normal, around the industry mean (30.262). P/E Ratio (67.114) is within average values for comparable stocks, (162.497). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.738). Dividend Yield (0.000) settles around the average of (0.083) among similar stocks. P/S Ratio (6.435) is also within normal values, averaging (56.493).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
CLBT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
N/A
Address
94 Shlomo Shmelzer Road
Phone
+972 733948000
Employees
1008
Web
https://www.cellebrite.com